Authors reply: The long and winding road of COVID‐19 in survivors of hospitalization
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Internal Medicine"
DOI: 10.1111/joim.13603
Abstract: We thank Dr. Oscar Jolobe for his insightful report [1] in response to our article [2]. Nirmatrelvir has surged as an orally administered antiviral agent that reduces coronavirus replication by inhibiting the SARS-CoV-2 3-chymotrypsin–like cysteine… read more here.
Keywords: road covid; reply long; covid survivors; winding road ... See more keywords